Alternatively, CAR targets against AML could involve antigens expressed on LB and LSC, entirely absent on CD34+ CD38− HSC/early progenitors, yet present on late hematopoietic progenitors and/or adult hematopoietic cells. The gene discussed is CD34; the disease is acute myeloid leukemia.